These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1041 related articles for article (PubMed ID: 31858341)

  • 1. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.
    Li L; Liu R; Zhang Y; Zhou J; Li Y; Xu Y; Gao S; Zheng Y
    Clin Rheumatol; 2020 May; 39(5):1457-1470. PubMed ID: 31858341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population.
    Fu Q; Wang L; Li L; Li Y; Liu R; Zheng Y
    Clin Rheumatol; 2019 Apr; 38(4):1109-1116. PubMed ID: 30535993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options.
    Chen N; Diao CY; Gao J; Zhao DB
    Semin Arthritis Rheum; 2022 Aug; 55():152004. PubMed ID: 35472663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.
    Kelly CA; Saravanan V; Nisar M; Arthanari S; Woodhead FA; Price-Forbes AN; Dawson J; Sathi N; Ahmad Y; Koduri G; Young A;
    Rheumatology (Oxford); 2014 Sep; 53(9):1676-82. PubMed ID: 24758887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
    Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
    Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis.
    Li L; Gao S; Fu Q; Liu R; Zhang Y; Dong X; Li Y; Li M; Zheng Y
    Clin Rheumatol; 2019 Nov; 38(11):3169-3178. PubMed ID: 31302858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease.
    Zhang Y; Li H; Wu N; Dong X; Zheng Y
    Clin Rheumatol; 2017 Apr; 36(4):817-823. PubMed ID: 28191607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution computed tomography of the lung in patients with rheumatoid arthritis: Prevalence of interstitial lung disease involvement and determinants of abnormalities.
    Salaffi F; Carotti M; Di Carlo M; Tardella M; Giovagnoni A
    Medicine (Baltimore); 2019 Sep; 98(38):e17088. PubMed ID: 31567944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
    Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
    Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progression.
    Tardella M; Di Carlo M; Carotti M; Giovagnoni A; Salaffi F
    Clin Rheumatol; 2021 Dec; 40(12):4861-4867. PubMed ID: 34313866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.
    Yang JA; Lee JS; Park JK; Lee EB; Song YW; Lee EY
    Korean J Intern Med; 2019 Mar; 34(2):434-441. PubMed ID: 28352064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.
    Detorakis EE; Magkanas E; Lasithiotaki I; Sidiropoulos P; Boumpas DT; Gourtsoyiannis N; Antoniou K; Raissaki M
    Clin Exp Rheumatol; 2017; 35(1):43-52. PubMed ID: 27908307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
    Avouac J; Cauvet A; Steelandt A; Shirai Y; Elhai M; Kuwana M; Distler O; Allanore Y
    PLoS One; 2020; 15(5):e0232978. PubMed ID: 32384128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
    Xie M; Zhu C; Ye Y
    BMC Pulm Med; 2023 Jul; 23(1):255. PubMed ID: 37434169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.
    Dai Y; Wang W; Yu Y; Hu S
    Clin Rheumatol; 2021 Apr; 40(4):1211-1220. PubMed ID: 32794076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management issues in rheumatoid arthritis-associated interstitial lung disease.
    England BR; Hershberger D
    Curr Opin Rheumatol; 2020 May; 32(3):255-263. PubMed ID: 32141954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis.
    Kurata I; Tsuboi H; Terasaki M; Shimizu M; Toko H; Honda F; Ohyama A; Yagishita M; Osada A; Ebe H; Kawaguchi H; Takahashi H; Hagiwara S; Asashima H; Kondo Y; Matsumoto I; Sumida T
    Intern Med; 2019 Jun; 58(12):1703-1712. PubMed ID: 30799358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre.
    Md Yusof MY; Kabia A; Darby M; Lettieri G; Beirne P; Vital EM; Dass S; Emery P
    Rheumatology (Oxford); 2017 Aug; 56(8):1348-1357. PubMed ID: 28444364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and radiological characteristics of rheumatoid arthritis-associated interstitial lung disease in a multi-ethnic Malaysian cohort.
    Ong SG; Ding HJ; Zuhanis AH; Aida AA; Norazizah IW
    Med J Malaysia; 2022 May; 77(3):292-299. PubMed ID: 35638484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
    Tyker A; Ventura IB; Lee CT; Strykowski R; Garcia N; Guzy R; Jablonski R; Vij R; Strek ME; Chung JH; Adegunsoye A
    Sci Rep; 2021 Nov; 11(1):22821. PubMed ID: 34819525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.